Disclaimer: This Blog owner & creator is not a research analyst and expresing opinion only as an Investor in Indian equities with his vast experience.He is not responsible for any loss arising out of any information, post or opinion appearing on this blog. Investors are advised to consult financial consultant before acting on any such information.
Thursday, December 17, 2015
FORTIS MALAR HOSPITALS LTD :- DARK HORSE
Today we are looking in to Health care sector stock for medium to long term investors,
Fortis Malar Hospitals Limited
Fortis Malar Hospital, formerly known as Malar Hospital, is one of the distinguished multi super-specialty corporate hospitals in Chennai providing comprehensive medical care in areas of cardiology, cardio-thoracic surgery, neurology, neurosurgery, orthopedics, nephrology, gynecology, gastroenterology, urology, pediatrics, diabetics and so on.
Established in 1992, Malar Hospital became a household name for tertiary care hospital services in Chennai over the years. Late 2007, Fortis Healthcare – India’s fastest growing hospital network, led by the vision of late Dr. Parvinder Singh of creating an integrated healthcare delivery system in India acquired stakes Malar Hospital Limited. Thus, paving the way to superlative healthcare services!
Fortis Malar Hospital has a vast pool of talented and experienced team of doctors, who are further supported by a team of highly qualified, experienced & dedicated support staff & cutting edge technology. Currently, more than 160 consultants and 650 employees work together to manage over 11000 inpatients in the last year alone. The hospital today has an infrastructure comprising of around 180 beds including about 60 ICU beds, 4 Operation theaters, state-of-the-art digital flat panel Cath lab, an ultra-modern dialysis unit besides a host of other world-class facilities.
Over the past 20 years, Fortis Malar Hospital has created benchmarks in cardiac care with their exemplary work. It is no surprise then, that today Fortis Maiar is considered a centre of excellence. Fortis Malar provide path breaking treatment in not just Cardiac Bypass Surgery, Minimally Invasive Surgery, Interventional Cardiology, and Non-invasive Cardiology, but also in Paediatric Cardiology and Paediatric Cardiac Surgery.
Promoter holding 63.21% stake, company posted 30.20 cr top line and 1.61 cr bottom line in latest quarter, Fortis Malar have 48.63 book value with 4.63 EPS, company,s NPM and OPM is highest in listed peers. Narayana helath care fixed 245-250 price band for fresh IPO , FORTIS MALAR is a undervalue stock .
Stock trading only in BSE @ 71.90 level, investor can buy @ current price and hold for medium to long term portfolio , this stock can move pass 3 digit mark in future.
Before buy a stock take advice from certified person,